Aggies up to No. 9 in latest tennis rankings

664 Views | 6 Replies | Last: 15 yr ago by Ags9192
Ags9192
How long do you want to ignore this user?
Per the ITA today. t.u. is at No. 3.

So this upcoming match is going to be a HUGE deal.
Ags9192
How long do you want to ignore this user?
Also, Austin Krajicek holds strong as the #5 singles player in the nation. Jeff Dadamo sits at #35.

Together, they're now the #4 doubles tandem in the nation, up from #5.
Raven
How long do you want to ignore this user?
S
Lou: thanks for the update.
jt2hunt
How long do you want to ignore this user?
AG
i think myself and kids are going to try and make it out for the matches.
bigfoot10s
How long do you want to ignore this user?
AG


[This message has been edited by bigfoot10s (edited 4/23/2010 8:15p).]
gobluwolverine
How long do you want to ignore this user?
Aggie women move up to 34, Texas women move up to 20.
K Blaine11
How long do you want to ignore this user?
AG
They deserve it! We'll be heading to Austin on Saturday for what should be another great matchup. Hopefully we'll see some more Ags out there. My parents and I, along with one other guy, were the only ones in Lubbock, and I know the guys really appreciated us coming out to support them.
Ags9192
How long do you want to ignore this user?
quote:
They deserve it! We'll be heading to Austin on Saturday for what should be another great matchup. Hopefully we'll see some more Ags out there. My parents and I, along with one other guy, were the only ones in Lubbock, and I know the guys really appreciated us coming out to support them.


I'm glad to hear it, and I'm glad for y'all's support. I would love to go, and I almost made plans for it, but my parents are coming on Saturday for Parents' Weekend and my dad wants to see M&W game + baseball. Made me sad because I wasn't sure how many other people would journey up to Austin for this one.

Try and recruit whoever you can!
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.